VC turmoil, GLP-1 competition, & the war on recovery

Come for Lev's great reporting on buprenorphine, stay to learn how to pronounce buprenorphine (and stay for the reporting, too, come on!)

March 8, 2024 Check out STAT+

Sponsored By

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is "Series E" a thing in biotech? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT's Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity. LISTEN NOW Subscribe to the podcast to never miss an episode iTunes Google Spotify SoundCloud Podcast Addict TuneIn Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser